|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2000031209 |
|
最近更新日期: Date of Last Refreshed on: |
2020-03-24 12:13:43 |
|
注册时间: Date of Registration: |
2020-03-24 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
杨显珺医师:请尽快上传伦理审批文件并填写伦理审批日期。 工具化饮食限制行为在肥胖干预治疗中的应用及效果评价 |
|
Public title: |
Instrumentalization of dieting in the management of obesity: a randomized controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
工具化饮食限制行为在肥胖干预治疗中的应用及效果评价 |
|
Scientific title: |
Instrumentalization of dieting in the management of obesity: a randomized controlled trial |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨显珺 |
研究负责人: |
杨显珺 |
|
Applicant: |
Xianjun Yang |
Study leader: |
Xianjun Yang |
|
申请注册联系人电话: Applicant telephone: |
+86 18608710680 |
研究负责人电话:
Study leader's |
+86 18608710680 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
phillins@163.com |
研究负责人电子邮件: Study leader's E-mail: |
phillins@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
昆明医科大学附属延安医院 |
研究负责人通讯地址: |
昆明医科大学附属延安医院 |
|
Applicant address: |
Yan'an Hospital Affiliated to Kunming Medical University |
Study leader's address: |
Yan'an Hospital Affiliated to Kunming Medical University |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
昆明医科大学附属延安医院 |
||
|
Applicant's institution: |
Yan'an Hospital Affiliated to Kunming Medical University |
||
|
研究负责人所在单位: |
昆明医科大学附属延安医院 |
||
|
Affiliation of the Leader: |
Yan'an Hospital Affiliated to Kunming Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2016-020-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
昆明医科大学附属延安医院伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of Yanan Hospital Affiliated to Kunming Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
李维镇 |
||
|
Contact Name of the ethic committee: |
Weizhen Li |
||
|
伦理委员会联系地址: |
昆明医科大学附属延安医院 |
||
|
Contact Address of the ethic committee: |
Yan'an Hospital Affiliated to Kunming Medical University |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
昆明医科大学附属延安医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Yanan Hospital Affiliated to Kunming Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
昆明市人民东路245号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
245 Renmin Road East, Panlong District, Kunming, Yunnan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
云南省应用基础研究(昆明医科大学联合专项) |
||||||||||||||||||||||
|
Source(s) of funding: |
Yunnan Applied Basic Research Projects |
||||||||||||||||||||||
|
研究疾病: |
肥胖 |
||||||||||||||||||||||
|
Target disease: |
obesity |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究的主要目标为探索“工具化”的限能量饮食落实方法能否与标准的限能量饮食落实方法在短期(6个月)体重干预周期内取得同等的减重效果,即两组研究对象在联合限能量饮食,增加运动量和应用认知-行为技巧帮助落实饮食和运动干预措施的综合生活方式干预6个月后均能实现减少初始体重的7%。同时,假设“工具化”的限能量饮食落实方法具有更好的依从性和满意度。 |
||||||||||||||||||||||
|
Objectives of Study: |
The primary objective of the present study is to assess if the instrumentalized dieting is noninferior to the standard dieting in a short-time weight loss program. These two dieting approaches combining with both physical exercise and behavior therapy could help participants lose 7% of initiate weight during a study period of 6 months. We assume that participants may adhere to the instrumentalized dieting more easily than to the standard dieting. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)18-60周岁长居昆明的超重和肥胖人群为主要招募对象,男女不限; |
||||||||||||||||||||||
|
Inclusion criteria |
A volunteer must: |
||||||||||||||||||||||
|
排除标准: |
(1)具有导致慢性营养不良和内分泌紊乱的疾病; |
||||||||||||||||||||||
|
Exclusion criteria: |
An individual if he/she: |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-05-01 00:00:00至 To 2020-10-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-04-15 00:00:00 至 To 2020-04-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
一名与本课题完成单位无关的统计专家根据课题组分配要求完成随机分配序列产生工作。在对研究对象分层后,每层按电脑产生的随机数字进行区组随机分配,区组长度按2、4、6随机产生。研究对象按1:1比例分配到实验组和对照组。分层因素包括性别、年龄、体质指数以及饮食控制自我效能量表评分(the Eating Self-Efficacy Scale)。分层界值:年龄(18-29,30-49,50-60),体质指数 (28-34.9, 35-40),饮食控制自我效能量表评分(按得分从低到高排序后,分为50%及以下和50%以上)。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
A statistician who is not a member of the study team will perform a stratified randomization with the restriction of blocking within strata using a computerized random number generator. The factors, including gender, age, BMI, and scores of the Eating Self-Efficacy Scale will be used for stratification. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
开放 |
|
Blinding: |
open label |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
公开原始数据的日期:本研究结束后的6个月内。公开原始数据的方式:ResMan, http://www.medresman.org.cn. |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The date of sharing IPD will be with a period of 6 months at the end of the study. The way of sharing IPD will use ResMan, http://www.medresman.org.cn. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集使用人工填写病历记录表,使用Microsoft Office Excel 2016, SPSS 22.0 和中国临床试验注册中心推荐的在线ResMan系统进行录入和管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Forms, Microsoft Office Excel 2016, SPSS 22.0 and ResMan. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |